Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. I.V. Specialty, Ltd
483
•I.V. Specialty, Ltd•February 5, 2016

I.V. Specialty, Ltd – FDA 483, Feb 5, 2016

Record Details

During an FDA inspection from January 25 to February 5, 2016, I.V. Specialty, Ltd., a producer of sterile drug products in Austin, TX, was cited with eight observations on Form FDA 483, several of which were repeat issues from a previous inspection. The primary violations centered on significant deficiencies in aseptic processing areas and quality control systems, indicating a failure to adhere to Good Manufacturing Practices (GMP).

Key issues included structural deficiencies in cleanrooms, such as damaged work surfaces, dirty HEPA covers, and non-compliant ceiling materials, leading to consistently high microbial counts and expired room certifications. The firm also failed to conduct adequate sterility and endotoxin testing for all sterile drug products, using unvalidated methods and improper procedures. Personnel gowning practices were inadequate, with non-sterile attire and improper aseptic techniques observed.

Further observations detailed a lack of established and followed procedures to prevent microbiological contamination, including poor glove hygiene, spraying near open sterile products, and using soiled or rusted equipment. Cleaning and disinfection protocols were insufficient, utilizing expired sanitizers and non-sterile tools, resulting in visible residues. Environmental monitoring was deficient, relying on third-party certification rather than internal, active monitoring. The company also lacked thorough investigations for discrepancies like product leaks or particles, and failed to formally address patient complaints. Finally, critical equipment, including calibration weights, incubator thermometers, and pressure gauges, were found to be uncalibrated, jeopardizing product quality.

To achieve compliance with the Federal Food, Drug, and Cosmetic Act, I.V. Specialty, Ltd. is required to implement comprehensive corrective and preventive actions to address these systemic failures in facility design, manufacturing controls, quality assurance, and equipment maintenance.

Company
I.V. Specialty, Ltd
Inspection date
February 5, 2016
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Massoud Motamed (Biologist at CBER)
  • Shelby N. Marler (Investigator)
View Company Profile

ID · 459e06c7-eb2f-4d08-beff-2a0d43ec7890

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for I.V. Specialty, Ltd
  • 483 - 2017-07-28July 28, 2017
  • WARNING_LETTER - 2014-07-22July 22, 2014
  • 483 - 2014-07-17July 17, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore I.V. Specialty, Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.